TORONTO and GLIL YAM, Israel

多伦多和以色列格利尔亚姆

,

，

Aug. 7, 2026

2026年8月7日

/PRNewswire/ --

/美通社/ --

IM Cannabis Corp.

IM大麻公司

('

('

IMC

IMC

' or the '

' 或 '

Company

公司

') (Nasdaq:

') (纳斯达克：

IMCC

国际海事犯罪中心

), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$250,000 convertible note financing in a private placement with an institutional investor (the '

），一家在以色列和德国开展业务的医用大麻公司，今日宣布完成一项与机构投资者进行的私募配售，金额为25万美元的可转换票据融资（“

Lender

贷款人

').

').

Pursuant to a note purchase agreement between the Company and Lender dated August 6, 2026 (the '

根据公司与贷款人于2026年8月6日签署的票据购买协议（“

August Note Purchase Agreement

八月票据购买协议

'), the Company issued the Lender a note in the principal amount of US$250,000, with an original issuance discount of 10% (the '

），本公司向贷款人签发了一张本金金额为25万美元的本票，原始发行折扣为10%（“

August Note

八月笔记

').

'）。

The August Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continuation of an event of default, as defined in the August Note. The August Note is not repayable in cash and the Company's obligations thereunder will be satisfied solely through the issuance of common shares in the capital of the Company (the '.

八月票据按年利率8%计息，在发生并持续存在违约事件（定义见八月票据）时，利率将上升至14%。八月票据不可用现金偿还，公司在该票据项下的义务将仅通过发行公司资本中的普通股股份来履行（“

Common Shares

普通股

') upon conversion.

转换时。

The conversion price in the August Note is set to the lower of (i) a fixed price of US$0.122 per Common Share, or (ii) 90% of the lowest daily volume-weighted average price during the 20 consecutive trading days preceding the conversion date, subject to a floor price of US$0.02436. The August Note includes customary limitations, including a 4.99% beneficial ownership cap..

八月票据的转换价格设定为以下两者中的较低者：(i) 每股普通股0.122美元的固定价格，或 (ii) 转换日前连续20个交易日内每日成交量加权平均价格的最低值的90%，但设有0.02436美元的底价。八月票据包含惯常限制，包括4.99%的受益所有权上限。

In connection with the August Note, the Company issued a warrant to purchase up to 2,052,545 Common Shares (the '

就八月票据而言，本公司发行了认股权证，允许购买最多2,052,545股普通股（“

August Note Warrants

八月票据认股权证

') at an exercise price of C$0.17 per Common Share. The August Note Warrants became immediately exercisable upon their issuance date, August 7, 2026, and will expire after five years, on August 7, 2031.

）行权价为每股普通股0.17加元。八月票据权证自其发行日2026年8月7日起即可立即行权，并将于五年后，即2031年8月7日到期。

The Company intends to use the net proceeds from the August Note for general corporate purposes.

本公司拟将八月票据所得款项净额用于一般公司用途。

In connection with the August Note Purchase Agreement, the Company has agreed to reserve sufficient Common Shares for issuance upon conversion of the August Note and exercise of the August Note Warrants and to file a resale registration statement on Form F-3 with the U.S. Securities and Exchange Commission (the '.

就八月票据购买协议而言，公司已同意预留足够的普通股股份，以便在转换八月票据及行使八月票据认股权证时发行，并向美国证券交易委员会提交一份F-3表格的转售注册声明。

SEC

美国证券交易委员会

') and to use commercially reasonable efforts to secure its effectiveness within the timeframes agreed with the Lender.

）并应尽商业上合理的努力，在与贷款人约定的时间框架内确保其有效性。

All securities issued under the financing described above are subject to: (i) a four month and one day hold period from the date of issuance and (ii) applicable legends as required pursuant to the U.S. Securities Act of 1933, as amended (the '

上述融资项下发行的所有证券均须遵守：(i) 自发行之日起为期四个月零一天的持有期；以及 (ii) 根据经修订的《1933年美国证券法》（“

Securities Act

证券法

'). The private placement of the securities offered to the Lender was made in reliance on an exemption from (x) registration under Section 4(a)(2) of the Securities Act and (y) applicable Canadian securities laws. Accordingly, the securities issued in the private placement may not be offered or sold in the United States or Canada except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws or an exemption pursuant to Canadian securities laws..

）。向贷款人提供的证券私募发行系依据以下豁免进行：(x)《证券法》第4(a)(2)条规定的注册豁免，以及(y)适用的加拿大证券法豁免。因此，除非依据生效的注册声明、或《证券法》及适用州证券法关于注册要求的适用豁免、或根据加拿大证券法的豁免，否则不得在美国或加拿大要约出售或出售该等私募发行的证券。

About IM Cannabis Corp.

关于IM Cannabis Corp.

IMC (Nasdaq:

IMC（纳斯达克：

IMCC

IMCC

) is an international company focused on building and scaling innovative businesses and technologies across global markets. The Company currently operates a medical cannabis platform serving patients in Israel and Germany while evaluating opportunities to expand into additional technology-driven sectors..

）是一家国际公司，专注于在全球市场建设和发展创新业务与技术。该公司目前运营一个医疗大麻平台，为以色列和德国的患者提供服务，同时评估向其他技术驱动型领域扩张的机会。

The IMC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms, in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain.

IMC生态系统通过其在以色列的子公司运营，这些子公司进口并向医疗患者分发大麻，利用多年的专有数据和患者洞察。该公司还在以色列运营医疗大麻零售药店和在线平台，确保IMC产品在整个价值链中的安全交付和质量控制。

In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients..

在德国，IMC生态系统通过Adjupharm GmbH运营，向药店分发大麻，供医用大麻患者使用。

Company Contact:

公司联系人：

Michal Efraty

米哈尔·埃夫拉蒂

Investor & Public Relations

投资者与公共关系

IM Cannabis Corp.

IM大麻公司

[email protected]

[email protected]

Oren Shuster, Chief Executive Officer

奥伦·舒斯特，首席执行官

IM Cannabis Corp.

IM大麻公司

[email protected]

[email protected]

Disclaimer for Forward-Looking Statements

前瞻性陈述免责声明

This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, '

本新闻稿包含根据适用的加拿大和美国证券法（统称为“

forward-looking statements

前瞻性陈述

'). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as 'seek', 'anticipate', 'believe', 'plan', 'estimate', 'expect', 'likely' and 'intend' and statements that an event or result 'may', 'will', 'should', 'could' or 'might' occur or be achieved and other similar expressions.

）。所有涉及我们预期未来将发生的活动或发展的信息均属于前瞻性陈述。前瞻性陈述通常（但并非总是）通过使用“寻求”、“预期”、“相信”、“计划”、“估计”、“期望”、“可能”和“打算”等词语，以及声称某事件或结果“可能”、“将会”、“应当”、“能够”或“或许”发生或实现的陈述，以及其他类似表述来识别。

Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to: the receipt of and use of proceeds from the financing and the preparation, timing and filing of the registration statement with the SEC.

前瞻性陈述基于管理层在作出这些陈述之日的估计和意见。在该新闻稿中，此类前瞻性陈述包括但不限于与以下事项相关的陈述：融资收益的收取和使用，以及向美国证券交易委员会（SEC）提交注册声明的准备、时间安排和递交。

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks.

上述前瞻性陈述及假设清单并非详尽无遗。由于前瞻性陈述涉及未来事件和状况，其性质本身即包含固有的风险和不确定性。受多种因素和风险的影响，实际结果可能与当前预期或此类前瞻性陈述所暗示的结果存在重大差异。

These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company's ability to continue to meet the listing requirements of the Nasdaq Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the '.

这些因素包括：公司在高度监管的行业未能遵守适用的监管要求；公司运营所在司法管辖区的政府政策和法规发生意外变化；公司持续满足纳斯达克资本市场上市要求的能力；任何未能保持良好信誉或续展许可证的意外情况；公司及其子公司（统称为“

Group

组

') to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group's obligations; the Group's possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group's cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the multi front war Israel is facing on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company's inability to take advantage of the legalization of medicinal cannabis in Germany; the Company's inability to use the proceeds as set out herein; and the Company's inability to file a registration statement in the timelines outlined here.

’）以履行其销售承诺或实现增长目标；集团依赖第三方供应协议来提供足够数量的医用大麻，以履行集团的义务；集团可能面临的法律责任、与此相关的感知风险水平，以及涉及集团的任何诉讼或其他类似纠纷或法律程序的预期结果；竞争加剧的影响；缺乏并购机会；不利的市场状况；产量、质量和成本估算固有的不确定性，以及产生意外成本和费用的可能性；因使用集团的大麻产品而产生的产品责任和其他与安全相关的责任风险；供应链限制；对关键人员的依赖；现有债务违约的风险；与东欧和中东地区的战争、冲突和内乱相关的风险，包括以色列面临的多线战争对公司、其在以色列的运营以及以色列医用大麻行业的影响；与公司专注于以色列和德国市场相关的风险；公司无法实现可持续盈利和/或提升股东价值；公司无法积极管理成本和/或提高利润率；公司无法增长和/或维持销售额；公司无法实现其目标和/或战略计划；公司无法降低成本和/或维持收入；公司无法利用德国医用大麻合法化的机遇；公司无法按本文所述使用所得款项；以及公司无法在本文规定的时间表内提交注册声明。

Please see the other risks, uncertainties and factors set out under the heading 'Risk Factors' in the Company's annual report for the year ended December 31, 2025, which is available on the Company's issuer profile on SEDAR+ at

请参阅本公司截至2025年12月31日止年度的年度报告中“风险因素”标题下所列的其他风险、不确定性和因素，该报告可在SEDAR+上的本公司发行人概况页面获取，网址为

www.sedarplus.ca

www.sedarplus.ca

and Edgar at

以及埃德加在

www.sec.gov/edgar

www.sec.gov/edgar

. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements, except as required by applicable securities laws.

本新闻稿中包含的任何前瞻性陈述均截至本新闻稿发布之日作出，并基于管理层在该等前瞻性信息作出之日的信念、估计、预期和观点。除非适用证券法律另有要求，公司不承担任何更新前瞻性陈述的义务。

Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement..

投资者不应过度依赖前瞻性陈述。本新闻稿中包含的前瞻性陈述明确受此警示性声明的限定。

Logo -

标志 -

https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

SOURCE IM Cannabis Corp.

来源：IM Cannabis Corp.

21

二十一

%

百分之

more press release views with

更多新闻稿浏览量

Request a Demo

申请演示